Loading…

Novartis is investing EUR 53 million to expand its radioligand therapy plant in La Almunia de Doña Godina, Spain, increasing production capacity fivefold and doubling export capacity. The expansion is expected to be completed in 2025.
“La planta de La Almunia de Doña Godina es una instalación clave para el liderazgo de Novartis en terapias con radioligandos.”eldiario.es
Summarized from public sources; check the original articles before acting on it.